~ Buy the VICTOZA (liraglutide recombinant) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR VICTOZA

All Clinical Trials for Victoza

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00993720 ↗	Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes	Completed	Hvidovre University Hospital	Phase 2/Phase 3	2009-10-01	The aim of the study is to investigate the effect of Victoza (a GLP-1 receptor agonist)on insulin-dose, risk of hypoglycemia and gastric emptying rate during hypoglycemia in patients with type 1 diabetes.
NCT01029886 ↗	Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes	Completed	Eli Lilly and Company	Phase 3	2010-01-01	No head to head comparisons between exenatide once weekly and liraglutide have been performed. Therefore, the purpose of this study is to compare exenatide once weekly to once-daily liraglutide with regard to HbA1c, body weight, subject-reported outcomes, and other clinical benefits. The study includes a 26-week treatment period and a safety follow-up visit 10 weeks after the final study drug dose.
NCT01029886 ↗	Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes	Completed	AstraZeneca	Phase 3	2010-01-01	No head to head comparisons between exenatide once weekly and liraglutide have been performed. Therefore, the purpose of this study is to compare exenatide once weekly to once-daily liraglutide with regard to HbA1c, body weight, subject-reported outcomes, and other clinical benefits. The study includes a 26-week treatment period and a safety follow-up visit 10 weeks after the final study drug dose.

Clinical Trial Conditions for Victoza

Condition Name

Condition Name for Victoza
Intervention	Trials
Type 2 Diabetes	27
Type 2 Diabetes Mellitus	19
Obesity	18

Condition MeSH

Condition MeSH for Victoza
Intervention	Trials
Diabetes Mellitus	69
Diabetes Mellitus, Type 2	61
Diabetes Mellitus, Type 1	15

Clinical Trial Locations for Victoza

Trials by Country

Trials by Country for Victoza
Location	Trials
United States	168
China	29
Canada	25
Denmark	21
Germany	10

Trials by US State

Trials by US State for Victoza
Location	Trials
California	13
New York	11
Texas	9
Florida	8
Ohio	7

Clinical Trial Progress for Victoza

Clinical Trial Phase

Clinical Trial Phase for Victoza
Clinical Trial Phase	Trials
Phase 4	45
Phase 3	22
Phase 2/Phase 3	5

Clinical Trial Status

Clinical Trial Status for Victoza
Clinical Trial Phase	Trials
Completed	80
Recruiting	12
Unknown status	12

Clinical Trial Sponsors for Victoza

Sponsor Name

Sponsor Name for Victoza
Sponsor	Trials
Novo Nordisk A/S	41
University of Copenhagen	5
Steno Diabetes Center Copenhagen	4

Sponsor Type

Sponsor Type for Victoza
Sponsor	Trials
Other	168
Industry	61
NIH	6